메뉴 건너뛰기




Volumn 70, Issue 6, 2006, Pages 994-999

The place of sirolimus in kidney transplantation: Can we reduce calcineurin inhibitor renal toxicity?

Author keywords

Kidney transplantation; Nephrotoxicity; Sirolimus

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN A; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS;

EID: 33748437522     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001644     Document Type: Review
Times cited : (38)

References (30)
  • 1
    • 0032105481 scopus 로고    scopus 로고
    • Rapamune (RAPA, rapamycin, sirolimus): Mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression
    • Sehgal S. Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 1998; 31: 335-340.
    • (1998) Clin Biochem , vol.31 , pp. 335-340
    • Sehgal, S.1
  • 2
    • 0030894459 scopus 로고    scopus 로고
    • Synergistic mechanisms by which sirolimus and cyclosporine inhibit rat heart and kidney allograft rejection
    • Stepkowski S, Tian L, Napoli K. Synergistic mechanisms by which sirolimus and cyclosporine inhibit rat heart and kidney allograft rejection. Clin Exp Immunol 1997; 108: 63-68.
    • (1997) Clin Exp Immunol , vol.108 , pp. 63-68
    • Stepkowski, S.1    Tian, L.2    Napoli, K.3
  • 3
    • 0026583694 scopus 로고
    • The effect of rapamycin on kidney function in the Sprague-Dawley rat
    • DiJoseph J, Sharma R, Chang J. The effect of rapamycin on kidney function in the Sprague-Dawley rat. Transplantation 1992; 52: 507-513.
    • (1992) Transplantation , vol.52 , pp. 507-513
    • DiJoseph, J.1    Sharma, R.2    Chang, J.3
  • 4
    • 0025789057 scopus 로고
    • Toxicity of rapamycin - A comparative and combination study with cyclosporine at immunotheraeutic dosage in the rat
    • Whiting P, Woo J, Adam B et al. Toxicity of rapamycin -a comparative and combination study with cyclosporine at immunotheraeutic dosage in the rat. Transplantation 1991; 52: 203-208.
    • (1991) Transplantation , vol.52 , pp. 203-208
    • Whiting, P.1    Woo, J.2    Adam, B.3
  • 5
    • 29544442641 scopus 로고    scopus 로고
    • Correlation between cyclosporine-induced nephrotoxicity in reduced nephron mass and expression of kidney injury molecule-1 and aquaporin-2 gene
    • Hong M, Hong J, Stepkowski S et al. Correlation between cyclosporine-induced nephrotoxicity in reduced nephron mass and expression of kidney injury molecule-1 and aquaporin-2 gene. Transplant Proc 2005; 37: 4254-4258.
    • (2005) Transplant Proc , vol.37 , pp. 4254-4258
    • Hong, M.1    Hong, J.2    Stepkowski, S.3
  • 6
    • 0028918672 scopus 로고
    • Effect of rapamycin on morphological and functional parameters in the kidney of the rabbit
    • Thliveris JA, Yatscoff RW. Effect of rapamycin on morphological and functional parameters in the kidney of the rabbit. Transplantation 1995; 59: 427-429.
    • (1995) Transplantation , vol.59 , pp. 427-429
    • Thliveris, J.A.1    Yatscoff, R.W.2
  • 7
    • 0035042276 scopus 로고    scopus 로고
    • Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations
    • Podder H, Steplowski S, Napoli K et al. Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations. J Am Soc Nephrol 2001; 12: 1059-1071.
    • (2001) J Am Soc Nephrol , vol.12 , pp. 1059-1071
    • Podder, H.1    Steplowski, S.2    Napoli, K.3
  • 8
    • 13144256680 scopus 로고    scopus 로고
    • The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent
    • Kaplan B, Meier-Kriesche H-U, Napoli KL et al. The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent. Clin Pharmacol Therapeut 1998; 63: 48-53.
    • (1998) Clin Pharmacol Therapeut , vol.63 , pp. 48-53
    • Kaplan, B.1    Meier-Kriesche, H.-U.2    Napoli, K.L.3
  • 9
    • 0034786155 scopus 로고    scopus 로고
    • Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: A randomized controlled trial
    • Reitamo S, Spuls P, Sassolas B et al. Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial. Br J Dermatol 2001; 145: 438-445.
    • (2001) Br J Dermatol , vol.145 , pp. 438-445
    • Reitamo, S.1    Spuls, P.2    Sassolas, B.3
  • 10
    • 0026694617 scopus 로고
    • Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases
    • International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases
    • Feutren G, Mihatsch M. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases. N Engl J Med 1992; 326: 1654-1660.
    • (1992) N Engl J Med , vol.326 , pp. 1654-1660
    • Feutren, G.1    Mihatsch, M.2
  • 11
    • 0030064388 scopus 로고    scopus 로고
    • The side effect profile of sirolimus: A phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients
    • Murgia M, Jordan S, Kahan B. The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients. Kidney Int 1996; 49: 209-216.
    • (1996) Kidney Int , vol.49 , pp. 209-216
    • Murgia, M.1    Jordan, S.2    Kahan, B.3
  • 12
    • 0032573044 scopus 로고    scopus 로고
    • Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation
    • Kahan B, Podbielski J, Napoli K et al. Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation. Transplantation 1998; 66: 1040.
    • (1998) Transplantation , vol.66 , pp. 1040
    • Kahan, B.1    Podbielski, J.2    Napoli, K.3
  • 13
    • 0033610638 scopus 로고    scopus 로고
    • Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: A phase II trial
    • Kahan BD, Julian BA, Pescovitz MD et al. Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: a phase II trial. Transplantation 1999; 68: 1526-1532.
    • (1999) Transplantation , vol.68 , pp. 1526-1532
    • Kahan, B.D.1    Julian, B.A.2    Pescovitz, M.D.3
  • 14
    • 0035956745 scopus 로고    scopus 로고
    • A worldwide, phase III, randomized, controlled safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts
    • MacDonald AS, for the Rapamune Study Group. A worldwide, phase III, randomized, controlled safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 2001; 71: 271.
    • (2001) Transplantation , vol.71 , pp. 271
    • MacDonald, A.S.1
  • 15
    • 33746530366 scopus 로고    scopus 로고
    • Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: A randomised multicentre study
    • Kahan BD, for the US Rapamune Study Group. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. Lancet 2000; 356: 194.
    • (2000) Lancet , vol.356 , pp. 194
    • Kahan, B.D.1
  • 16
    • 10044273197 scopus 로고    scopus 로고
    • Sirolimus with neoral versus mycophenolate mofetil with neoral is associated with decreased renal allograft survival
    • Meier-Kriesche H, Steffen B, Chu A et al. Sirolimus with neoral versus mycophenolate mofetil with neoral is associated with decreased renal allograft survival. Am J Transplant 2004; 4: 2058-2066.
    • (2004) Am J Transplant , vol.4 , pp. 2058-2066
    • Meier-Kriesche, H.1    Steffen, B.2    Chu, A.3
  • 17
    • 23744462171 scopus 로고    scopus 로고
    • A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 1 year
    • Mendez R, Gonwa T, Yang H et al. A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year. Transplantation 2005; 80: 303-309.
    • (2005) Transplantation , vol.80 , pp. 303-309
    • Mendez, R.1    Gonwa, T.2    Yang, H.3
  • 18
    • 0037623477 scopus 로고    scopus 로고
    • Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients
    • Russ G, Campbell S, Chadban S et al. Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients. Transplant Proc 2003; 35: 10010-11710.
    • (2003) Transplant Proc , vol.35 , pp. 10010-11710
    • Russ, G.1    Campbell, S.2    Chadban, S.3
  • 19
    • 21644457432 scopus 로고    scopus 로고
    • Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation
    • Oberbauer R, Segoloni G, Campistol J et al. Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transplant Int 2005; 18: 2005.
    • (2005) Transplant Int , vol.18 , pp. 2005
    • Oberbauer, R.1    Segoloni, G.2    Campistol, J.3
  • 20
    • 3542995706 scopus 로고    scopus 로고
    • Pilot randomized study of early tacrolimus withdrawal from a regimen with sirolimus plus tacrolimus in kidney transplantation
    • Grinyo J, Campistol J, Paul J et al. Pilot randomized study of early tacrolimus withdrawal from a regimen with sirolimus plus tacrolimus in kidney transplantation. Am J Transplant 2004; 4: 1308-1314.
    • (2004) Am J Transplant , vol.4 , pp. 1308-1314
    • Grinyo, J.1    Campistol, J.2    Paul, J.3
  • 21
    • 2942534405 scopus 로고    scopus 로고
    • Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years
    • Mota A, Arias M, Taskinen E et al. Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years. Am J Transplant 2004; 4: 953-961.
    • (2004) Am J Transplant , vol.4 , pp. 953-961
    • Mota, A.1    Arias, M.2    Taskinen, E.3
  • 22
    • 33645945017 scopus 로고    scopus 로고
    • Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients
    • Stallone G, Infante B, Schena A et al. Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients. J Am Soc Nephrol 2005; 16: 3755-3762.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 3755-3762
    • Stallone, G.1    Infante, B.2    Schena, A.3
  • 23
    • 19244366256 scopus 로고    scopus 로고
    • Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients
    • Morales J, Wramner L, Kreis H et al. Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients. Am J Transplant 2002; 2: 436-442.
    • (2002) Am J Transplant , vol.2 , pp. 436-442
    • Morales, J.1    Wramner, L.2    Kreis, H.3
  • 24
    • 7244220158 scopus 로고    scopus 로고
    • De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years
    • Flechner S, Kurian S, Solez K et al. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 2004; 4: 1776-1785.
    • (2004) Am J Transplant , vol.4 , pp. 1776-1785
    • Flechner, S.1    Kurian, S.2    Solez, K.3
  • 25
    • 33644889043 scopus 로고    scopus 로고
    • Complete avoidance of calcineurin inhibitors in renal transplantation: A randomized trial comparing sirolimus and tacrolimus
    • Larson T, Dean P, Stegall M et al. Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant 2006; 6: 514-522.
    • (2006) Am J Transplant , vol.6 , pp. 514-522
    • Larson, T.1    Dean, P.2    Stegall, M.3
  • 26
    • 0034789534 scopus 로고    scopus 로고
    • Rapamycin impairs recovery from acute renal failure: Role of cell-cycle arrest and apoptosis of tubular cells
    • Lieberthal W, Fuhro R, Andry CC et al. Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol 2001; 281: F693-F706.
    • (2001) Am J Physiol , vol.281
    • Lieberthal, W.1    Fuhro, R.2    Andry, C.C.3
  • 27
    • 0346848743 scopus 로고    scopus 로고
    • Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury
    • Fuller TF, Freise C, Serkova N et al. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation 2003; 76: 1594-1599.
    • (2003) Transplantation , vol.76 , pp. 1594-1599
    • Fuller, T.F.1    Freise, C.2    Serkova, N.3
  • 28
    • 0038666511 scopus 로고    scopus 로고
    • Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation
    • McTaggart R, Gottlieb D, Brooks J et al. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant 2003; 3: 413-423.
    • (2003) Am J Transplant , vol.3 , pp. 413-423
    • McTaggart, R.1    Gottlieb, D.2    Brooks, J.3
  • 29
    • 0037378763 scopus 로고    scopus 로고
    • Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use
    • Smith K, Wrenshall L, Nicosia R et al. Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J Am Soc Nephrol 2003; 14: 1037-1045.
    • (2003) J Am Soc Nephrol , vol.14 , pp. 1037-1045
    • Smith, K.1    Wrenshall, L.2    Nicosia, R.3
  • 30
    • 4644258361 scopus 로고    scopus 로고
    • The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low versus high risk for delayed graft function
    • Knight RJ, Kerman RH, Schoenberg L et al. The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low versus high risk for delayed graft function. Transplantation 2004; 78: 904-910.
    • (2004) Transplantation , vol.78 , pp. 904-910
    • Knight, R.J.1    Kerman, R.H.2    Schoenberg, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.